Japan headquartered Shionogi & Co. has entered into a comprehensive partnership agreement with Nagasaki University, ...
President Donald J. Trump signed an Executive Order to facilitate the restoration of a robust domestic manufacturing bas...
Merck KGaA, Darmstadt, Germany, a leading science and technology company, and SpringWorks Therapeutics, Inc., a US-based...
-Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of its ma...
UK-based Oxford Nanopore Technologies, the global company behind a new generation of nanopore-based molecular sensing te...
Ruch De Silva, Head of Patient & Payor Solutions and M&A Lead, DKSH Innovation, accessibility, and global marke...
Cytiva, a global leader in life sciences, has expanded its industry-leading MabSelect™ protein A resin portfolio w...
The WHO Foundation and the L’Oréal Groupe, spearheaded by its Dermatological Beauty Division...
The Ministry of Health in Egypt has signed a Memorandum of Understanding (MoU) with Siemens Healthineers on to launch th...
The World Vaccine Congress Washington 2025, the largest and most influential global vaccine event, is officially open fo...
Australia-based Telix Pharmaceuticals has announced that the Brazilian Health Regulatory Agency (Agencia Nacional d...
British pharmaceutical firm AstraZeneca has entered into a definitive agreement to acquire Belgium-based biotech startup...
Elsevier, a global leader in advanced information and decision support, launches ScienceDirect AI, a cutting-edge g...
The year 2025 is set to be a pivotal year for the health, bioscience, and biopharma sectors, as emerging trends shape he...
Taiwan's Mycenax and Sartorius have entered into a strategic partnership to create comprehensive biopharmaceutical manuf...
Amid intensifying U.S.-China trade tensions, Beijing has escalated its retaliatory measures by banning U.S. biot...
To continue to help customers address the rapidly evolving cyber threat landscape, A10 Networks (NYSE: ATEN) has acquire...
Over the past decade, interest in Antibody-Drug Conjugates (ADCs) has surged, driven by their promise for patients, adva...
